| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 3 Apr 2025 | 27 Mar 2025 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/04/2025 inter alia to consider and approve amendments in the terms of Rights issue of equity shares of the Company Announcement with respect to the amendments to the terms of Rights issue of equity shares as partly paid up equity shares instead of fully paid up equity shares, as approved by the Board of Directors on 3rd April 2025. Outcome of Board meeting held on 3rd April 2024 is attached herewith. (As Per BSE Announcement Dated on: 03/04/2025) | ||
| Board Meeting | 27 Feb 2025 | 10 Feb 2025 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. Intimation of adjournment of Board meeting and closure of trading window (As Per Bse Announcement Dated on 14.02.2025) INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2025 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. A Board meeting for considering the said financial results was conducted on 14-02-2025 for which due intimation was given on 10-02-2025. That Board meeting could not consider said financial results since the financial statements of the material subsidiaries could not be consolidated due to unforeseen circumstances. The said financial results is being considered at an adjourned meeting to be held on 27-02-2024. While giving this intimation to Stock Exchange there is no provision to choose adjourned meeting in the given descriptions hence we have chosen Board meeting rescheduled in the description. Therefore we request you to kindly take note of the adjourned Board meeting. (As Per Bse Announcement Dated on 26.02.2025) Financial results and Limited review report for the quarter and nine months ended 31, December 2024 (As Per Bse Announcement Dated on 27.02.2025) Clarification letter on delay in submission of unaudited financial results for the quarter and nine months ended December 31, 2024 is attached. (As Per Bse Announcement Dated on 28.02.2025) | ||
| Board Meeting | 14 Nov 2024 | 11 Nov 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2024 and Rights issue of equity shares Results (As Per BSE Announcement Dated on 15.11.2024) | ||
| Board Meeting | 14 Aug 2024 | 8 Aug 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve The Meeting of the Board of Director of the Company is Scheduled on 14-08-2024 inter-alia to consider and approve the Standalone and Consolidated unaudited financial results for the quarter ended June 30 2024. Outcome of the Board Meeting held on 14-08-2024 is Attached. (As Per Bse Announcement Dated on 14.08.2024) | ||
| Board Meeting | 27 Jul 2024 | 24 Jul 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve the following items of business: 1. To approve the increase and reclassification of authorized share capital of the company subject to the approval of the shareholders. 2. To increase the limit of investment in the total paid up capital of the Company by foreign portfolio investors foreign institutional investors and non-resident Indians subject to the approval of the shareholders. 3. To consider and approve material related party transactions between the Company and subsidiaries subject to the approval of the shareholders. 4. To consider and approve Directors report and annexures thereon. 5. To take note of the Secretarial audit report 6. To fix the date time venue and mode of 32ndAnnual General Meeting of the Company and approve the draft Notice for convening the said General Meeting. 7. To appoint the Scrutinizer for 32ndAnnual General Meeting of the Company. 8. Other business matters. Please find attached outcome of Board meeting pursuant to Regulation 30 of SEBI LODR Regulations, 2015 (As Per BSE Announcement dated on 27.07.2024) | ||
| Board Meeting | 30 May 2024 | 23 May 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31 2024 along with audit report of Statutory auditors and other business matters. Approved the audited financial results along with audited report for the quarter and year ended 31 March 2024. (As Per BSE Announcement Dated on 31.05.2024) Please find attached updates. (As Per BSE Announcement dated on 01.07.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
